Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Ch...
Madrigal Research Site, Viborg, Denmark
Madrigal Research Site, Seattle, Washington, United States
Celerion, Tempe, Arizona, United States
Celerion, Tempe, Arizona, United States
PRACS Institute (formerly Cetero Research), Fargo, North Dakota, United States
Cetero Research, Fargo, North Dakota, United States